LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 7, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Lixte Biotechnology Holdings, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company that it is ultimately respo… | Read Filing EDGAR |
| Jul. 24, 2025 | CORRESP | Concern from SEC | Moderate | Lixte Biotechnology Holdings, Inc. responded to comments from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the comp… | Read Filing EDGAR |
| Jul. 16, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Lixte Biotechnology Holdings, Inc.'s Form 10-K for the fiscal year ended December 31, 2024, and has issued several comments regarding the company's disclosure… | Read Filing EDGAR |
| Jul. 14, 2025 | CORRESP | Neutral/Informational | Moderate | Lixte Biotechnology Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking to have the re… | Read Filing EDGAR |
| Jun. 26, 2025 | CORRESP | Neutral/Informational | Low | Lixte Biotechnology Holdings, Inc. has formally withdrawn its request for the acceleration of the effective date of its Registration Statement on Form S-1, which was initially req… | Read Filing EDGAR |
| Jun. 24, 2025 | CORRESP | Neutral/Informational | Moderate | Lixte Biotechnology Holdings, Inc. has submitted a request for the acceleration of the effective date of their Registration Statement No. 333-288120 on Form S-1/A. The request, ma… | Read Filing EDGAR |
| Jun. 24, 2025 | CORRESP | Neutral/Informational | Moderate | Lixte Biotechnology Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for the regist… | Read Filing EDGAR |
| May. 7, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence informs Lixte Biotechnology Holdings, Inc. that they do not intend to review the company's draft registration statement submitted on May 2, 2025. The SEC re… | Read Filing EDGAR |